Published May 14, 2012 on LawsuitInformation.org
According to court documents, on May 7th 2012, a Virginia woman, Abbdella Brown, filed a lawsuit in Ohio Northern District Court (case no. 1:2012dp21074) against DePuy Orthopaedics alleging she suffered serious injuries due to ASR Hip Implant Device. DePuy Orthopeadics, a subsidiary of Johnson & Johnson, is defending lawsuits in multidistrict litigations alleging that its ASR hip replacement (MDL 2197) and the metal-on-metal Pinnacle hip replacement systems (MDL 2244) were defectively designed. In August 2010, the DePuy ASR hips were recalled.
San Diego, CA (PRWEB) May 14, 2012
The media spotlight is often a double-edged sword. No one knows this better than Abbdella Brown. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke.
According to court documents, on May 7th 2012, a 51-year-old woman from Williamsburg, Virginia, Abbdella Brown, filed a lawsuit in Ohio Northern District Court (case no. 1:2012dp21074) against DePuy Orthopaedics, a subsidiary of Johnson & Johnson, alleging she suffered serious injuries due to ASR Hip Implant Device. Plaintiff was implanted with a DePuy ASR hip implant in February 2007.
In October 2010, Brown suffered pain, as well as elevated chromium and cobalt levels resulting in the need for revision surgery, allegedly due to her implants. Brown had the ASR hip replacements explanted in June 2011. In August 2010, a Johnson And Johnson Recall of the DePuy ASR was announced.
DePuy Orthopeadics is defending lawsuits in Multidistrict Litigations alleging that its ASR hip replacement (MDL 2197) and the metal-on-metal Pinnacle hip replacement systems (MDL 2244) were defectively designed.
More than 6,000 lawsuits are pending against Johnson & Johnson over its defective DePuy ASR hip replacements. Judge David A. Katz, who is overseeing the federal MDL in the U.S. District Court for the Northern District of Ohio, said it includes about 4,200 suits. The other 2,000 cases are filed in state courts, including Nevada, Florida, California, Maryland, Utah and Wisconsin.
In March 2012, results of a study presented at the British Hip Society Annual Conference, showed that DePuy ASR XL device had a higher than anticipated early failure rate as the rate of second operations, or revisions, ranged from 21% after four years to 49% after six years.
